alexa Toxicity, Drug Interactions & Follow-up In Hematopoietic Stem Cell Transplantation | 91459
ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

World Congress on Pathology and Microbiology

Manila, Philippines
Share This Page

Toxicity, drug interactions & follow-up in hematopoietic stem cell transplantation


Yener Koc

Antalya Medicalpark Hospitals, Turkey

Keynote: J Clin Exp Pathol

DOI: 10.4172/2161-0681-C1-044

To establish and maintain high cure rates and low mortality in the area of hematopoietic stem cell transplantation, accesibility and availability of well-trained experts capable of interpretation of toxicity and drug interactions at 24/7 hours basis and prompt management side-effects is absolutely necessary, besides trained nurses understanding pathophysiology and clinical signs of transplant complications including graft versus host disease (GVHD), a man-made disease, threatening patients survival and quality of life which may last months or years. Recently, an independent varible called ‘center effect’ is being stated in international transplant meetings, corresponding to transplant center’s expertise and ability that may lead to higher posttransplant survival rates above the world average. JACIE accredited transplant centers have also been shown to be associated with lower mortality and higher survival rates as satted in EBMT publications. Management of transplant complications including drug toxicity and interactions play a key role in patient outcome and development of expertise in this area requires intense training at a successful transplant center and dedication of skillfull attendings to management of transplant patients.

Yener Koc completed Hematology training at Boston University followed by Bone Marrow Transplant training between 1996-1999 at New England Medical Center, USA. He was given Outstanding Physician Award, twice at Boston University. He performed more than 1700 transplants in 24 years at centers accredited by European and International Transplant Registries (EBMT, CIBMTR) with low transplant mortality and cure rates above world average, including haploidentical allogeneic transplants. He has numerous publications in peer reviewed journals on 84 research items with 1347 citations over the past 33 years. He is working as JACIE accreditation inspector in EBMT since 2004.

E-mail: [email protected]